<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A significant proportion of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients experience <z:hpo ids='HP_0002018'>nausea</z:hpo> or <z:hpo ids='HP_0002013'>vomiting</z:hpo> during the course of their disease, either because of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> itself or because of the treatment received </plain></SENT>
<SENT sid="1" pm="."><plain>Highly or moderately emetogenic drugs are part of the standard chemotherapy regimens frequently used in patients with <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>, <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e>, and several other common <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In this review, we describe the impact of <z:hpo ids='HP_0002017'>nausea and vomiting</z:hpo> in patients receiving chemotherapy, and the main progress achieved in the prophylaxis of chemotherapy-induced <z:hpo ids='HP_0002017'>nausea and vomiting</z:hpo> with the introduction of neurokinin 1 inhibitors </plain></SENT>
<SENT sid="3" pm="."><plain>The adherence to existing guidelines is particularly important to avoid suboptimal prophylaxis and maximize patients' outcome </plain></SENT>
<SENT sid="4" pm="."><plain>This review is focused on lung, breast, ovarian, and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, which are among the <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> characterized by a numeric and clinical relevance of the chemotherapy-induced <z:hpo ids='HP_0002017'>nausea and vomiting</z:hpo> issue because of the wide use of highly and/or moderately emetogenic chemotherapy regimens </plain></SENT>
</text></document>